H.R.1862 - Regenerative Medicine Promotion Act of 2011
To launch a national strategy to support regenerative medicine through funding for research and commercial development of regenerative medicine products and development of a regulatory environment that enables rapid approval of safe and effective products, and for other purposes. view all titles (2)
All Bill Titles
- Official: To launch a national strategy to support regenerative medicine through funding for research and commercial development of regenerative medicine products and development of a regulatory environment that enables rapid approval of safe and effective products, and for other purposes. as introduced.
- Short: Regenerative Medicine Promotion Act of 2011 as introduced.
This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.
| All Actions | |
|---|---|
| May 12th | Referred to the House Committee on Energy and Commerce. |
| May 12th | Introduced in House |
| May 13th | Referred to the Subcommittee on Health. |

U.S. Congress - H.R.1862 Regenerative Medicine Promotion Act of 2011



